A recent review in JAMA reveals that low-dose corticosteroids may reduce mortality in critically ill adults with severe pulmonary infections, including COVID-19, community-acquired bacterial pneumonia, and Pneumocystis pneumonia.
The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.
Savara's experimental therapy, molgramostim, shows potential in treating a rare disease that causes breathing difficulties, offering hope for patients with autoimmune pulmonary alveolar proteinosis (aPAP).
Reuters
Daily News
Stay up to date with the latest clinical headlines.
New nationwide study reveals significantly higher risk of hospital readmission for individuals living with HIV in the U.S., emphasizing the need for long-term antiretroviral therapy and subspecialty care. #HIV #HealthcareResearch
A systematic review and meta-analysis reveals that traditional mind-body exercises improve lung function, exercise capacity, and quality of life in patients with COPD.
A study published in JAMA Internal Medicine revealed that nicotine-containing e-cigarettes and varenicline significantly outperformed placebo in helping over 40% of participants achieve smoking abstinence at 6 months.